IntelGenx Corp.   Report issue

For profit Phase 2
Founded: Saint Laurent Canada (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2018
NCT03402503
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

IntelGenx Corp.